ABSTRACT
Interstitial lung diseases (ILD) of childhood are a heterogeneous group of diseases that are rare and have high mortality and morbidity. Multidisciplinary evaluation is required in the diagnosis and follow-up of these diseases. Radiological imaging methods, especially computed tomography, play an important role in diagnosis. In this review, imaging methods and imaging findings used in the diagnosis of childhood ILD are presented with the current clinic-pathological classification system.
Keywords: Interstitial lung disease, childhood, computed tomography
References
1
Hime NJ, Zurynski Y, Fitzgerald D, Selvadurai H, Phu A, Deverell M, et al. Childhood interstitial lung disease: a systematic review. Pediatr Pulmonol 2015; 50: 1383-92.
2
Lee EY. Interstitial lung disease in infants: new classification system, imaging technique, clinical presentation and imaging findings. Pediatr Radiol 2013; 43: 3-13.
3
Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007; 176: 1120-8.
4
Kurland G, Deterding RR, Hagood JS, Young LR, Brody AS, Castile RG, et al. An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med 2013; 188: 376-94.
5
Lee EY. Pediatric interstitial (diffuse) lung disease. Imaging in Pediatric Pulmonology 2019: 145-97.
6
Schittny JC. Development of the lung. Cell Tissue Res 2017; 367: 427-44.
7
Copley SJ, Coren M, Nicholson AG, Rubens MB, Bush A, Hansell DM. Diagnostic accuracy of thin-section CT and chest radiography of pediatric interstitial lung disease. AJR Am J Roentgenol 2000; 174: 549-54.
8
Semple T, Winant AJ, Lee EY. Childhood ınterstitial lung disease: ımaging guidelines and recommendations. Radiol Clin North Am 2022; 60: 83-111.
9
Salamon E, Lever S, Kuo W, Ciet P, Tiddens HA. Spirometer guided chest imaging in children: it is worth the effort! Pediatr Pulmonol 2017; 52: 48-56.
10
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246: 697-722.
11
Serai SD, Rapp JB, States LJ, Andronikou S, Ciet P, Lee EY. Pediatric lung MRI: currently available and emerging techniques. AJR Am J Roentgenol 2021; 216: 781-90.
12
Sodhi KS, Sharma M, Lee EY, Saxena AK, Mathew JL, Singh M, et al. Diagnostic utility of 3T lung MRI in children with interstitial lung disease: a prospective pilot study. Acad Radiol 2018; 25: 380-6.
13
Semple TR, Ashworth MT, Owens CM. Interstitial lung disease in children made easier…well, almost. Radiographics 2017; 37: 1679-703.
14
Stankiewicz P, Sen P, Bhatt SS, Storer M, Xia Z, Bejjani BA, et al. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 2009; 84: 780-91.
15
Dishop MK. Diagnostic pathology of diffuse lung disease in children. Pediatr Allergy Immunol Pulmonol 2010; 23: 69-85.
16
Coalson JJ. Pathology of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 179-84.
17
Semple T, Akhtar MR, Owens CM. Imaging bronchopulmonary dysplasia-a multimodality update. Front Med (Lausanne) 2017; 4: 88.
18
Biko DM, Schwartz M, Anupindi SA, Altes TA. Subpleural lung cysts in Down syndrome: prevalence and association with coexisting diagnoses. Pediatr Radiol 2008; 38: 280-4.
19
Shelmerdine SC, Semple T, Wallis C, Aurora P, Moledina S, Ashworth MT, et al Filamin A (FLNA) mutation-A newcomer to the childhood interstitial lung disease (ChILD) classification. Pediatr Pulmonol 2017; 52: 1306-15.
20
Frémond ML, Hadchouel A, Berteloot L, Melki I, Bresson V, Barnabei L, et al. Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients. J Allergy Clin Immunol Pract 2021; 9: 803-18.e11.
21
Singh J, Jaffe A, Schultz A, Selvadurai H. Surfactant protein disorders in childhood interstitial lung disease. Eur J Pediatr 2021; 180: 2711-21.
22
Valimahamed-Mitha S, Berteloot L, Ducoin H, Ottolenghi C, de Lonlay P, de Blic J. Lung involvement in children with lysinuric protein intolerance. J Inherit Metab Dis 2015; 38: 257-63.
23
Yonker LM, Kinane TB. Pediatric interstitial lung disease: thyroid transcription factor-1 mutations and their phenotype potpourri. Chest 2013; 144: 728-30.
24
Doan ML, Guillerman RP, Dishop MK, Nogee LM, Langston C, Mallory GB, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008; 63: 366-73.
25
Liszewski MC, Lee EY. Neonatal lung disorders: pattern recognition approach to diagnosis. AJR Am J Roentgenol 2018; 210: 964-75.
26
van Moorsel CH, van Oosterhout MF, Barlo NP, de Jong PA, van der Vis JJ, Ruven HJ, et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. Am J Respir Crit Care Med 2010; 182: 1419-25.
27
Mechri M, Epaud R, Emond S, Coulomb A, Jaubert F, Tarrant A, et al. Surfactant protein C gene (SFTPC) mutation-associated lung disease: high-resolution computed tomography (HRCT) findings and its relation to histological analysis. Pediatr Pulmonol 2010; 45: 1021-9.
28
Cutz E, Chami R, Dell S, Langer J, Manson D. Pulmonary interstitial glycogenosis associated with a spectrum of neonatal pulmonary disorders. Hum Pathol 2017; 68: 154-65.
29
Ross MK, Ellis LS, Bird LM, Hagood JS. Pulmonary interstitial glycogenosis in a patient ultimately diagnosed with Noonan syndrome. Pediatr Pulmonol 2014; 49: 508-11.
30
Weinman JP, White CJ, Liptzin DR, Deterding RR, Galambos C, Browne LP. High-resolution CT findings of pulmonary interstitial glycogenosis. Pediatr Radiol 2018; 48: 1066-72.
31
Brody AS, Guillerman RP, Hay TC, Wagner BD, Young LR, Deutsch GH, et al. Neuroendocrine cell hyperplasia of infancy: diagnosis with high-resolution CT. AJR Am J Roentgenol 2010; 194: 238-44.
32
Flanagan F, Casey A, Reyes-Múgica M, Kurland G. Post-infectious bronchiolitis obliterans in children. Paediatr Respir Rev 2022; 42: 69-78.
33
Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, et al. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur Respir J 2014; 44: 1479-503.
34
Li YN, Liu L, Qiao HM, Cheng H, Cheng HJ. Post-infectious bronchiolitis obliterans in children: a review of 42 cases. BMC Pediatr 2014; 14: 238.
35
Gunn ML, Godwin JD, Kanne JP, Flowers ME, Chien JW. High-resolution CT findings of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. J Thorac Imaging 2008; 23: 244-50.
36
Griese M, Haug M, Hartl D, Teusch V, Glöckner-Pagel J, Brasch F et al. Hypersensitivity pneumonitis: lessons for diagnosis and treatment of a rare entity in children. Orphanet J Rare Dis 2013; 8: 121.
37
Fan LL, Mullen AL, Brugman SM, Inscore SC, Parks DP, White CW. Clinical spectrum of chronic interstitial lung disease in children. J Pediatr 1992; 121: 867-72.
38
Zanetti G, Marchiori E, Gasparetto TD, Escuissato DL, Soares Souza A Jr. Lipoid pneumonia in children following aspiration of mineral oil used in the treatment of constipation: high-resolution CT findings in 17 patients. Pediatr Radiol 2007; 37: 1135-9.
39
Giovannini-Chami L, Blanc S, Hadchouel A, Baruchel A, Boukari R, Dubus JC, et al. Eosinophilic pneumonias in children: A review of the epidemiology, diagnosis, and treatment. Pediatr Pulmonol 2016; 51: 203-16.
40
Jariwala MP, Laxer RM. Primary Vasculitis in Childhood: GPA and MPA in Childhood. Front Pediatr 2018; 6: 226.
41
Guillerman RP. Imaging of childhood interstitial lung disease. Pediatr Allergy Immunol Pulmonol 2010; 23: 43-68.
42
Lilleby V, Aaløkken TM, Johansen B, Førre Ø. Pulmonary involvement in patients with childhood-onset systemic lupus erythematosus. Clin Exp Rheumatol 2006; 24: 203-8.
43
Aaløkken TM, Lilleby V, Søyseth V, Mynarek G, Pripp AH, Johansen B, et al. Chest abnormalities in juvenile-onset mixed connective tissue disease: assessment with high-resolution computed tomography and pulmonary function tests. Acta Radiol 2009; 50: 430-6.
44
Gülhan B, Özçelik U, Gürakan F, Güçer Ş, Orhan D, Cinel G, et al. Different features of lung involvement in Niemann-Pick disease and Gaucher disease. Respir Med 2012; 106: 1278-85.
45
McHugh K, Olsen E ØE, Vellodi A. Gaucher disease in children: radiology of non-central nervous system manifestations. Clin Radiol 2004; 59: 117-23.
46
Odame I, Li P, Lau L, Doda W, Noseworthy M, Babyn P, et al. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood. Pediatr Blood Cancer 2006; 47: 889-93.
47
Bano S, Chaudhary V, Narula MK, Anand R, Venkatesan B, Mandal S, et al. Pulmonary Langerhans cell histiocytosis in children: a spectrum of radiologic findings. Eur J Radiol 2014; 83: 47-56.
48
Nathan N, Sileo C, Calender A, Pacheco Y, Rosental PA, Cavalin C, et al. Paediatric sarcoidosis. Paediatr Respir Rev 2019; 29: 53-9.
49
Nott K, Nott V, Lever E, Deakin C, Galloway J, Fisher C, Compeyrot-Lacassagne S. Pediatric sarcoidosis: retrospective analysis of biopsy-proven patients. J Rheumatol 2023; 50: 924-33.
50
Nathan N, Marcelo P, Houdouin V, Epaud R, de Blic J, Valeyre D, et al. Lung sarcoidosis in children: update on disease expression and management. Thorax 2015; 70: 537-42.
51
Gedalia A, Khan TA, Shetty AK, Dimitriades VR, Espinoza LR. Childhood sarcoidosis: Louisiana experience. Clin Rheumatol 2016; 35: 1879-84.
52
Hoffmann AL, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979-1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr 2004; 93: 30-6.
53
Becciolini V, Gudinchet F, Cheseaux JJ, Schnyder P. Lymphocytic interstitial pneumonia in children with AIDS: high-resolution CT findings. Eur Radiol 2001; 11: 1015-20.
54
Jodele S, Hirsch R, Laskin B, Davies S, Witte D, Chima R. Pulmonary arterial hypertension in pediatric patients with hematopoietic stem cell transplant-associated thrombotic microangiopathy. Biol Blood Marrow Transplant 2013; 19: 202-7.
55
Dandoy CE, Rotz S, Alonso PB, Klunk A, Desmond C, Huber J, et al. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Blood Adv 2021; 5: 1-11.
56
Nguyen HN, Das S, Gazzaneo MC, Melicoff E, Mallory GB, Eldin KW, et al. Clinico-radiologic features of pleuroparenchymal fibroelastosis in children. Pediatr Radiol 2019; 49: 1163-70.
57
Oh S lin, Lee JW, Yoo SY, Kim JH, Kim YJ, Han J, et al. Pleuroparenchymal fibroelastosis after hematopoietic stem cell transplantation in children: a propensity score-matched analysis. Eur Radiol 2023; 33: 2266-76.
58
Enomoto Y, Nakamura Y, Satake Y, Sumikawa H, Johkoh T, Colby TV, et al. Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study. Respir Med 2017; 133: 1-5.
59
Naeem M, Ballard DH, Jawad H, Raptis C, Bhalla S. Noninfectious granulomatous diseases of the chest. Radiographics 2020; 40: 1003-19.
60
Sood AK, Funkhouser W, Handly B, Weston B, Wu EY. Granulomatous-lymphocytic ınterstitial lung disease in 22q11.2 deletion syndrome: a case report and literature review. Curr Allergy Asthma Rep 2018; 18: 14.
61
Frazier AA, Franks TJ, Mohammed TL, Ozbudak IH, Galvin JR. From the archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis. Radiographics 2007; 27: 867-82.
62
Bellini C, Boccardo F, Campisi C, Bonioli E. Congenital pulmonary lymphangiectasia. Orphanet J Rare Dis 2006; 1: 43.
